We report a successful living related liver transplantation from a donor with von Willebrand's disease. With proper preparation, a substantial liver resection can be performed safely in such patients, and the transplanted liver will function normally.
Successful liver transplantation from a living donor with asymptomatic pulmonary cryptococcosis
โ Scribed by Michinori Matsumoto; Yoshiaki Kita; Takeshi Gocho; Shigeki Wakiyama; Taro Sakamoto; Tomonori Iida; Takeyuki Misawa; Yuichi Ishida; Katsuhiko Yanaga
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 141 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22236
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We describe our use of a liver allograft from a donor who died of intracranial hemorrhage after brodifacoum ingestion. Because brodifacoum can remain in the human body for months, the recipient's posttransplantation coagulation profiles and serum brodifacoum levels were monitored closely. Her posttr
Pulmonary arterial hypertension (PAH) associated with portal hypertension [portopulmonary hypertension (PPHTN)] occurs in 2% to 10% of patients with advanced liver disease and carries a very poor prognosis without treatment. Most hepatic transplantation centers consider moderate to severe PPHTN to b
In Asia, various cultural, social, and historic factors have severely limited the availability of deceased donor organs. Therefore, living donor liver transplantation (LDLT) has emerged as an important therapeutic option for patients with end-stage liver disease. According to data reported to the Ko
The demographics of patients in the United States who undergo living donor liver transplantation (LDLT) versus patients who undergo deceased donor liver transplantation (DDLT) are interesting with respect to the demographics of the donor service areas (DSAs). We examined adult recipients of primary,